Table 2 Docking results of test compounds against SARS-CoV-2 targets
Compound # | 6LU7 | 7BV2 | 6W4H |
|---|---|---|---|
Mpro | RdRp-Mg | Methyltransferase | |
1 | − 7.8 | − 6.8 | − 8.1 |
2 | − 7.6 | − 6.2 | − 8.3 |
3 | − 7.9 | − 6.7 | − 8.2 |
4 | − 8.3 | − 5.8 | − 8.3 |
5 | − 7.8 | − 5.8 | − 8.5 |
6 | − 8 | − 7.1 | − 8.2 |
7 | − 8 | − 6 | − 7.6 |
8 | − 8.6 | − 7.8 | − 8.8 |
9 | − 8.3 | − 7.5 | − 8.6 |
10 | − 8.5 | − 7.6 | − 8.9 |
Co-crystalized Ligand | − 7.8 (N3 inhibitor) | − 6.9 (Remdesivir) | − 8.1 (SAM) |